A new report from Pen State University has found heavy metals in cannabis crops that are impacting consumer and patient health.
Studies show the need for clearer labelling and increased transparency around CBD, THC and Delta-8 levels in US products.
Harvesting of high-THC strains is expected at its subsidiary’s Portugal facility by the end of January 2022.
Linneo Health CEO shares his thoughts on future trends in the cannabis industry.
Glass Pharms will begin the domestic supply of medical cannabis in the UK from the world’s first carbon-negative cannabis cultivation facility.
Christopher Tasker of Global Cannabinoid Solutions (GCS) discusses the rise of delta-8-THC.
The new Common Agricultural Policy has been adopted in Europe that will allow a maximum THC level on the field of 0.3 per cent.
A new report has highlighted that the UK industry is struggling under ‘scientifically unjustified, and ethically unacceptable’ toxicity testing for CBD products.
Linneo Health has had its GMP certification renewed for its quality control laboratory and its post-harvest facility.
The NACA has signed three groundbreaking agreements which support the use of tribal farmland for cannabis cultivation.
Materia announced that its wholly-owned subsidiary, Materia Malta, has received the licence from the Malta Medicines Authority.
We won’t spam you
